Incyte Corporation
Incyte Corporation (INCY) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · INCY · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
42
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Incyte Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
INCY insider buying and selling by quarter
INCY insider selling · INCY insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · INCY ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
INCY executive sell shares · INCY board member insider trading · INCY insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | Tray Thomas PAO | Option | 2,639 | $221K | Form 4 |
| Jun 4, 2026 | Tray Thomas PAO | Sale | 2,639 | $264K | Form 4 |
| May 26, 2026 | Tray Thomas PAO | Sale | 2,051 | $200K | Form 4 |
| May 26, 2026 | BIENAIME JEAN JACQUES Director | Option | 15,000 | $1.27M⚡ | Form 4 |
| May 26, 2026 | BIENAIME JEAN JACQUES Director | Other | 13,059 | $1.27M⚡ | Form 4 |
| May 19, 2026 | Clancy Paul J Director | Option | 15,000 | $1.27M⚡ | Form 4 |
| May 19, 2026 | Clancy Paul J Director | Sale | 15,000 | $1.42M⚡ | Form 4 |
| May 8, 2026 | BAKER BROS. ADVISORS LP Director | Option | 15,000 | $1.27M⚡ | Form 4 |
| May 8, 2026 | BAKER BROS. ADVISORS LP Director | Option | 15,000 | $1.27M⚡ | Form 4 |
| May 4, 2026 | Upadhyay Suketu EVP & Chief Financial Officer | Award | 26,343 | — | Form 4 |
| Apr 17, 2026 | CAGNONI PABLO J President, Global Head of R&D | Option | 12,590 | $906K | Form 4 |
| Apr 17, 2026 | CAGNONI PABLO J President, Global Head of R&D | Option | 6,077 | $390K | Form 4 |
| Apr 17, 2026 | CAGNONI PABLO J President, Global Head of R&D | Sale | 18,667 | $1.80M⚡ | Form 4 |
| Apr 15, 2026 | Meury William Director | Option | 125,000 | — | Form 4 |
| Apr 15, 2026 | CAGNONI PABLO J President, Global Head of R&D | Award | 27,892 | — | Form 4 |
| Apr 15, 2026 | Stein Steven H CMO & Head of Late-Stage Dev. | Award | 39,049 | — | Form 4 |
| Mar 31, 2026 | BAKER BROS. ADVISORS LP Director | Award | 421 | — | Form 4 |
| Mar 31, 2026 | BAKER BROS. ADVISORS LP Director | Award | 421 | — | Form 4 |
| Mar 31, 2026 | HARRIGAN EDMUND Director | Award | 269 | $25K | Form 4 |
| Mar 31, 2026 | Clancy Paul J Director | Award | 265 | $25K | Form 4 |
| Mar 25, 2026 | Trotta Matteo EVP, GM, Dermatology US | Other | 537 | $50K | Form 4 |
| Mar 17, 2026 | CAGNONI PABLO J President, R&D | Option | 11,501 | $739K | Form 4 |
| Mar 17, 2026 | CAGNONI PABLO J President, R&D | Option | 7,166 | $438K | Form 4 |
| Mar 17, 2026 | CAGNONI PABLO J President, R&D | Sale | 18,667 | $1.76M⚡ | Form 4 |
| Feb 19, 2026 | CAGNONI PABLO J President, R&D | Option | 5,575 | $341K | Form 4 |
BIENAIME JEAN JACQUES
Director
Date
May 26
Shares
15,000
Price
$84.53
Value
$1.27M ⚡
BIENAIME JEAN JACQUES
Director
Date
May 26
Shares
13,059
Price
$97.10
Value
$1.27M ⚡
BAKER BROS. ADVISORS LP
Director
Date
May 8
Shares
15,000
Price
$84.53
Value
$1.27M ⚡
BAKER BROS. ADVISORS LP
Director
Date
May 8
Shares
15,000
Price
$84.53
Value
$1.27M ⚡
Upadhyay Suketu
EVP & Chief Financial Officer
Date
May 4
Shares
26,343
Price
—
Value
—
CAGNONI PABLO J
President, Global Head of R&D
Date
Apr 17
Shares
12,590
Price
$71.93
Value
$906K
CAGNONI PABLO J
President, Global Head of R&D
Date
Apr 17
Shares
6,077
Price
$64.25
Value
$390K
CAGNONI PABLO J
President, Global Head of R&D
Date
Apr 17
Shares
18,667
Price
$96.50
Value
$1.80M ⚡
CAGNONI PABLO J
President, Global Head of R&D
Date
Apr 15
Shares
27,892
Price
—
Value
—
Stein Steven H
CMO & Head of Late-Stage Dev.
Date
Apr 15
Shares
39,049
Price
—
Value
—
Trotta Matteo
EVP, GM, Dermatology US
Date
Mar 25
Shares
537
Price
$92.23
Value
$50K
CAGNONI PABLO J
President, R&D
Date
Mar 17
Shares
11,501
Price
$64.25
Value
$739K
CAGNONI PABLO J
President, R&D
Date
Mar 17
Shares
18,667
Price
$94.24
Value
$1.76M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About INCY insider trading
INCY insider trades
Incyte Corporation (INCY) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CAGNONI PABLO J (President, Global Head of R&D), Stein Steven H (CMO & Head of Late-Stage Dev.), Tray Thomas (PAO). Over the past 12 months, 5 insiders have filed transactions with the SEC. INCY insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Incyte Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
INCY insider trading · 5 questionsThe insiders of Incyte Corporation (INCY) include executives and directors such as CAGNONI PABLO J (President, Global Head of R&D), Stein Steven H (CMO & Head of Late-Stage Dev.), Tray Thomas (PAO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026